Elsevier

Human Pathology

Volume 23, Issue 7, July 1992, Pages 755-761
Human Pathology

Original contribution
Microvessel quantitation and prognosis in invasive breast carcinoma

https://doi.org/10.1016/0046-8177(92)90344-3Get rights and content

Abstract

The prognostic significance of microvessel quantitation in invasive breast carcinoma was analyzed in a study group that comprised 88 patients with axillary node-negative carcinoma and 32 patients with axillary node-positive carcinoma who had a minimum follow-up period of 9 years. Microvessels were identified by immunohistochemistry using antibodies to endothelial markers, including factor VIII-related antigen and blood group isoantigens (ABH). Factor VIII-related antigen staining provided more consistent results for microvessel quantitation than did staining for ABH isoantigens. The three most vascular areas within a tumor were selected, and the microvessels within a ×200 microscopic field of each area were counted by two investigators simultaneously. Node-positive carcinomas demonstrated significantly higher microvessel counts than did node-negative carcinomas (mean ± SD, 99 ± 42 and 73 ± 22, respectively; P < .001). In node-negative carcinomas, tumors from patients who experienced distant recurrence had higher microvessel counts than did tumors from patients who were disease-free (84 ± 19 and 70 ± 22; P = .01). Similarly, in patients with node-positive carcinoma, microvessel counts were considerably higher in tumors from patients who experienced distant recurrence than in patients who did not, although the difference did not reach statistical significance (113 ± 44 and 93 ± 34, respectively). Among patients with node-negative carcinoma, those with a microvessel count of less than 84 had a recurrence rate of 20% compared with 57% in patients with counts greater than 84 (P = .003). Microvessel counts were independent of histologic parameters, ploidy status, and S-phase fraction but correlated with peritumoral vascular invasion. Both microvessel counts and vascular invasion were independent prognostic parameters by multivariate analysis. High vessel counts may represent increased tumor angiogenesis and are correlated with tumor aggressiveness. Microvessel quantitation may be an additional prognostic factor that, when used in conjunction with more established parameters, can help in appropriate patient management.

References (24)

  • EV Sugarbaker

    Cancer metastasis: A product of tumor-host interactions

    Curr Probl Cancer

    (1979)
  • LA Liotta et al.

    Cancer metastasis and angiogenesis: An imbalance of positive and negative regulation

    Cell

    (1991)
  • WL McGuire

    Adjuvant therapy of node-negative breast cancer

    N Engl J Med

    (1989)
  • VT DeVita

    Breast cancer therapy: Exercising all our options

    N Engl J Med

    (1989)
  • WL McGuire et al.

    How to use prognostic factors in axillary node-negative breast cancer patients

    J Natl Cancer Inst

    (1990)
  • CL Carter et al.

    Relation of tumor size, lymph node status, and survival in 24,740 breast cancer cases

    Cancer

    (1989)
  • HJ Bloom et al.

    Histological grading and prognosis in breast cancer: A study of 1409 cases of which 359 have been followed for 15 years

    Br J Cancer

    (1957)
  • CW Elston

    Grading of invasive carcinoma of the breast

  • AKC Lee et al.

    Prognostic significance of peritumoral lymphatic and blood vessel invasion in node-negative carcinoma of the breast

    J Clin Oncol

    (1990)
  • N Weidner et al.

    Tumor angiogenesis and metastasis: Correlation in invasive breast carcinoma

    N Engl J Med

    (1991)
  • A Srivastava et al.

    The prognostic significance of tumor vascularity in intermediate-thickness (0.76–4.0 mm thick) skin melanoma: A quantitative histologic study

    Am J Pathol

    (1988)
  • AK Lee

    Basement membrane and endothelial antigens: Their role in evaluation of tumor invasion and metastasis

  • Cited by (577)

    • Anti-tumor effects of triptolide on angiogenesis and cell apoptosis in osteosarcoma cells by inducing autophagy via repressing Wnt/β-Catenin signaling

      2018, Biochemical and Biophysical Research Communications
      Citation Excerpt :

      Metastasis of malignant tumor is a complex biological behavior and angiogenesis is the morphological basis of tumor growth and metastasis. Previous research demonstrated that micro-vascular density is closely related to the metastasis, occurrence and prognosis of a variety of tumors, including osteosarcoma [7]. Apoptosis is an important self-destruction process in cells which helps to scavenge aging and abnormal cells.

    • Correlation of microvessel parameters in invasive ductal carcinoma of the breast and fibroadenomas: a morphometric study

      2016, Annals of Diagnostic Pathology
      Citation Excerpt :

      Hence, for determination of cutoff between benign and malignant lesions, MVD was not as reliable as other parameters viz. VC, VCSA, %TVCSA, and TVBD. According to the Poiseuille's equation, flow rate of blood through a capillary is directly proportional to the fourth power of its radius [25-27]. One can use the information of VC with MVD to estimate blood flow rate per unit area of tissue.

    • Tumor Angiogenesis in Breast Cancer: Pericytes and Maturation Does Not Correlate with Lymph Node Metastasis and Molecular Subtypes

      2016, Clinical Breast Cancer
      Citation Excerpt :

      In the present study, the mean MVD was 145 vessels/mm2, higher than that reported in other studies such as that by Kanjanapanjapol et al,12 but lower than that reported by Biesaga et al,13 in which the mean MVD was 182.9 vessels vessels/mm2. Although studies have reported significant correlations between the vessel count and tumor size in patients with breast cancer, in our study, the MVD did not increase in proportion to the tumor size.14-16 The results of the present study, however, showed a significantly greater MVD for grade 3 tumors than for grade 2 and 1 tumors, which has not been reported by any previous studies.

    View all citing articles on Scopus

    Supported in part by the Eleanor Naylor Dana Charitable Trust Foundation, New York, NY, and by the National Cancer Institute, grant no. CA 40395.

    View full text